Editas Medicine dismissed Ernst & Young as its independent auditor effective April 1, 2026, and appointed PwC as replacement, with no disagreements or adverse opinions reported.
Key takeaways
Audit Committee dismissed Ernst & Young effective April 1, 2026, after review of proposals.
Appointed PwC as new independent auditor effective immediately for fiscal year ending December 31, 2026.
Ernst & Young prior reports for 2024 and 2025 had no adverse, qualified, or modified opinions.
No disagreements with Ernst & Young during 2024-2025 or interim through April 1, 2026.
No prior consultations with PwC on accounting or audit matters.
Ernst & Young letter confirms agreement with Item 4.01 disclosures (Exhibit 16.1).